These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 38892067)

  • 41. Using omics approaches to understand pulmonary diseases.
    Kan M; Shumyatcher M; Himes BE
    Respir Res; 2017 Aug; 18(1):149. PubMed ID: 28774304
    [TBL] [Abstract][Full Text] [Related]  

  • 42. From Genomics to Omics Landscapes of Parkinson's Disease: Revealing the Molecular Mechanisms.
    Redenšek S; Dolžan V; Kunej T
    OMICS; 2018 Jan; 22(1):1-16. PubMed ID: 29356624
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Holistic Integration of Omics Tools for Precision Nutrition in Health and Disease.
    Ramos-Lopez O; Martinez JA; Milagro FI
    Nutrients; 2022 Sep; 14(19):. PubMed ID: 36235725
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Data integration and mechanistic modelling for breast cancer biology: Current state and future directions.
    Mo H; Breitling R; Francavilla C; Schwartz JM
    Curr Opin Endocr Metab Res; 2022 Jun; 24():None. PubMed ID: 36034741
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Advancing drug-response prediction using multi-modal and -omics machine learning integration (MOMLIN): a case study on breast cancer clinical data.
    Rashid MM; Selvarajoo K
    Brief Bioinform; 2024 May; 25(4):. PubMed ID: 38904542
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Integrative multi-omics and systems bioinformatics in translational neuroscience: A data mining perspective.
    O'Connor LM; O'Connor BA; Lim SB; Zeng J; Lo CH
    J Pharm Anal; 2023 Aug; 13(8):836-850. PubMed ID: 37719197
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A critical review of datasets and computational suites for improving cancer theranostics and biomarker discovery.
    Ashok G; Ramaiah S
    Med Oncol; 2022 Sep; 39(12):206. PubMed ID: 36175717
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An overview of technologies for MS-based proteomics-centric multi-omics.
    Rajczewski AT; Jagtap PD; Griffin TJ
    Expert Rev Proteomics; 2022 Mar; 19(3):165-181. PubMed ID: 35466851
    [TBL] [Abstract][Full Text] [Related]  

  • 49. From single- to multi-omics: future research trends in medicinal plants.
    Yang L; Yang Y; Huang L; Cui X; Liu Y
    Brief Bioinform; 2023 Jan; 24(1):. PubMed ID: 36416120
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Deep Learning-Based Multi-Omics Integration Robustly Predicts Survival in Liver Cancer.
    Chaudhary K; Poirion OB; Lu L; Garmire LX
    Clin Cancer Res; 2018 Mar; 24(6):1248-1259. PubMed ID: 28982688
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comprehensive multi-omics analysis and experimental verification reveal PFDN5 is a novel prognostic and therapeutic biomarker for gastric cancer.
    Shao Y; Yesseyeva G; Zhi Y; Zhou J; Zong J; Zhou X; Fan X; Li S; Huang L; Zhang S; Dong F; Yang X; Zheng M; Sun J; Ma J
    Genomics; 2024 Mar; 116(2):110821. PubMed ID: 38447684
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Integrative methods for analyzing big data in precision medicine.
    Gligorijević V; Malod-Dognin N; Pržulj N
    Proteomics; 2016 Mar; 16(5):741-58. PubMed ID: 26677817
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A clinician's guide to omics resources in dermatology.
    Doolan BJ; McGrath JA; Onoufriadis A
    Clin Exp Dermatol; 2022 May; 47(5):858-866. PubMed ID: 35104371
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Omics-based novel strategies in the diagnosis of endometriosis.
    Samare-Najaf M; Razavinasab SA; Samareh A; Jamali N
    Crit Rev Clin Lab Sci; 2024 May; 61(3):205-225. PubMed ID: 37878077
    [TBL] [Abstract][Full Text] [Related]  

  • 55. scMNMF: a novel method for single-cell multi-omics clustering based on matrix factorization.
    Qiu Y; Guo D; Zhao P; Zou Q
    Brief Bioinform; 2024 Mar; 25(3):. PubMed ID: 38754408
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Integration of transcriptomics, proteomics, and metabolomics data to reveal HER2-associated metabolic heterogeneity in gastric cancer with response to immunotherapy and neoadjuvant chemotherapy.
    Yuan Q; Deng D; Pan C; Ren J; Wei T; Wu Z; Zhang B; Li S; Yin P; Shang D
    Front Immunol; 2022; 13():951137. PubMed ID: 35990657
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Towards multi-omics characterization of tumor heterogeneity: a comprehensive review of statistical and machine learning approaches.
    Lee D; Park Y; Kim S
    Brief Bioinform; 2021 May; 22(3):. PubMed ID: 34020548
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Omics studies for comprehensive understanding of immunoglobulin A nephropathy: state-of-the-art and future directions.
    Schena FP; Serino G; Sallustio F; Falchi M; Cox SN
    Nephrol Dial Transplant; 2018 Dec; 33(12):2101-2112. PubMed ID: 29905852
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A multi-omics data simulator for complex disease studies and its application to evaluate multi-omics data analysis methods for disease classification.
    Chung RH; Kang CY
    Gigascience; 2019 May; 8(5):. PubMed ID: 31029063
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Multi-omic data integration and analysis using systems genomics approaches: methods and applications in animal production, health and welfare.
    Suravajhala P; Kogelman LJ; Kadarmideen HN
    Genet Sel Evol; 2016 Apr; 48(1):38. PubMed ID: 27130220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.